about
Alzheimer's disease: Unique markers for diagnosis & new treatment modalitiesClinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status.The role of clusterin in amyloid-β-associated neurodegeneration.Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer diseaseCognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.Enrichment and stratification for predementia Alzheimer disease clinical trials.Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults.Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer diseaseTask-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkersAge, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study.A diffusion model analysis of episodic recognition in preclinical individuals with a family history for Alzheimer's disease: The adult children study.Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.Alzheimer's disease diagnostic criteria: practical applications.Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study.Brain injury biomarkers are not dependent on β-amyloid in normal elderly.Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individualsBeta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.Neuroinflammation in Alzheimer's disease: from pathogenesis to a therapeutic target.Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlifeMolecular and cellular pathophysiology of preclinical Alzheimer's disease.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.Model-based clustering for assessing the prognostic value of imaging biomarkers and mixed type tests.
P2860
Q28085139-3A87005F-AE28-410E-BCDB-478D206207D3Q33638836-2BDD3C5B-140A-4C60-97D4-14F35B47A8FEQ33988464-597C64AE-E9D5-47EC-8A8A-4B6B2B532F37Q34112954-FE749402-5144-4E3E-9645-CBA6CE94546FQ34311853-23BC3E0B-458B-4257-A08B-FC80AC8B59E0Q34452239-79232BF8-90D1-4874-A84C-169C98E1A771Q35185590-E58AD868-3EB6-4444-AA1C-928A30430E15Q35195654-D2E8A91C-D912-4150-BD1A-028DBBCAE635Q35561661-52D5374F-CD78-4BEA-846F-DD12F3852D82Q35598271-59CB6343-21BE-4044-A1C1-6DBAD2EC03F8Q36175421-8BEDBEE2-92D4-4970-B932-8F149CD5BCC3Q36484068-C55D4AD6-2E1B-46D9-8C74-EFE014E035F2Q36526176-DFD640FD-19A1-44BB-9720-5C5F0A60025BQ36632807-C335E29B-2BCF-4181-A524-37F740499C44Q36813260-F6B91F17-8018-4740-9EDE-D842C13A3FDEQ36863815-67293935-1B50-495B-A2C4-86F09A050D42Q36943464-A4B13F52-194A-4B9F-8893-5549BF0253C2Q37100074-3484D28E-B68C-44C4-ACDD-F2AFA54222E5Q37184248-2F8EFA6F-9527-4775-9DB3-FDD49BA0C145Q38202910-301241A0-81A0-4281-B9CD-32989C509C14Q38391075-CFE69A81-F655-4A0C-AC13-F62298F1A829Q38836004-F14CD5D8-592E-41B4-B061-ED3C0B6FD9C4Q38979999-739E1249-9C81-4BB3-89B6-74E08AD3F3BDQ39779168-16CB5FBA-3F39-453A-B3CE-1443B9657F8DQ47665196-BF1740BE-F3F5-4229-9250-DF021636BBD0
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Toward a multifactorial model of Alzheimer disease.
@ast
Toward a multifactorial model of Alzheimer disease.
@en
type
label
Toward a multifactorial model of Alzheimer disease.
@ast
Toward a multifactorial model of Alzheimer disease.
@en
prefLabel
Toward a multifactorial model of Alzheimer disease.
@ast
Toward a multifactorial model of Alzheimer disease.
@en
P2860
P50
P1476
Toward a multifactorial model of Alzheimer disease.
@en
P2093
Denise Head
Martha Storandt
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2011.11.029
P577
2012-01-20T00:00:00Z